9
Views
0
CrossRef citations to date
0
Altmetric
Miscellaneous

Molecular diagnostic patents January to September 1999: part 3 - enabling technology

Pages 143-151 | Published online: 25 Feb 2005
 

Abstract

Roche occupies the number one position in this survey of patent documents published in the first nine months of 1999 that are concerned with the underlying, or enabling, technologies. There is a strong emphasis toward nucleic acid based approaches, and the list of top companies includes those with their own proprietary amplification methods. These technologically active companies are gaining a competitive edge over those that are still focused on the older immunoassay technologies, or those that have no underlying technology R&D of their own.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.